Detalhe da pesquisa
1.
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms.
J Transl Med
; 16(1): 360, 2018 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30558676
2.
Epigenetics in Myeloproliferative Neoplasms.
J Cell Mol Med
; 21(9): 1660-1667, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28677265
3.
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics.
BMC Bioinformatics
; 17(1): 198, 2016 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27143038
4.
A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.
Br J Haematol
; 163(1): 118-22, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23909468
5.
Modification of the Histone Landscape with JAK Inhibition in Myeloproliferative Neoplasms.
Cancers (Basel)
; 12(9)2020 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32962027
6.
Methylation age as a correlate for allele burden, disease status, and clinical response in myeloproliferative neoplasm patients treated with vorinostat.
Exp Hematol
; 79: 26-34, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31563618
7.
Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha.
Ann Hematol
; 90(2): 233-4, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20512575
8.
Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.
Case Rep Hematol
; 2012: 458716, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22937329
9.
Serum erythropoietin at diagnosis in low grade myelodysplastic syndrome correlates with both red cell zinc protoporphyrin and serum lactic dehydrogenase (LDH) and may reflect severity of ineffective erythropoiesis.
Leuk Lymphoma
; 50(6): 1036-8, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19367500